- idUS
- Listar por autor
Listar por autor "Nadal, Ernest"
Mostrando ítems 1-6 de 6
-
Artículo
Blood biomarkers associated to complete pathologicalresponse on NSCLC patients treated with neoadjuvantchemoimmunotherapy included in NADIM clinical trial
Laza-Briviesca, Raquel; Cruz Bermúdez, Alberto; Nadal, Ernest; Insa, Amelia; García Campelo, María del Rosario; Huidobro, Gerardo; Bernabé-Caro, Reyes; Provencio, Mariano (Wiley Open Access, 2021-07-14)Background:Immunotherapy is being tested in early-stage non-small cell lungcancer (NSCLC), and achieving higher rates of ...
-
Artículo
Clinical and molecular parameters associated to pneumonitis development in non-small-cell lung cancer patients receiving chemoimmunotherapy from NADIM trial
Sierra Rodero, Belén; Cruz Bermúdez, Alberto; Nadal, Ernest; Bernabé-Caro, Reyes; Provencio, Mariano (BMC, 2021)Background Pneumonitis (Pn) is one of the main immune-related adverse effects, having a special importance in lung cancer, ...
-
Artículo
Clinical and molecular parameters associated to pneumonitis development in non-small-cell lung cancer patients receiving chemoimmunotherapy from NADIM trial
Sierra-Rodero, Belén; Cruz-Bermúdez, Alberto; Nadal, Ernest; Garitaonaindiá, Yago; Insa, Amelia; Bernabé Caro, María Reyes; Provencio, Mariano (BMC, 2021)Background Pneumonitis (Pn) is one of the main immune-related adverse effects, having a specialimportance in lung cancer, ...
-
Artículo
Genetic and cellular sensitivity of Caenorhabditis elegans to the chemotherapeutic agent cisplatin
García-Rodríguez, Francisco Javier; Martínez-Fernández, Carmen; Brena, David; Kukhtar, Dmytro; Serrat, Xènia; Nadal, Ernest; Boxem, Mike; Honnen, Sebastian; Miranda Vizuete, Antonio; Villanueva, Alberto; Cerón, Julián (Company of Biologists Limited, 2018-06-21)Cisplatin and derivatives are commonly used as chemotherapeutic agents. Although the cytotoxic action of cisplatin on ...
-
Artículo
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non–Small-Cell Lung Cancer (NADIM phase II trial)
Provencio, Mariano; Serna Blasco, Roberto; Nadal, Ernest; Insa, Amelia; García Campelo, M. Rosario; Casal Rubio, Joaquín; Bernabé-Caro, Reyes; Romero, Atocha (AMER SOC CLINICAL ONCOLOGY, 2022)PURPOSE Neoadjuvant chemotherapy plus nivolumab has been shown to be effective in resectable non–small cell lung cancer ...
-
Artículo
Pretreatment tissue TCR repertoire evenness is associated with complete pathologic response in patients with NSCLC receiving neoadjuvant chemoimmunotherapy
Casarrubios, Marta; Cruz-Bermúdez, Alberto; Nadal, Ernest; Insa, Amelia; del Rosario García Campelo, María; Lázaro, Martín; Dómine, Manuel; Caro, Reyes Bernabé; Provencio, Mariano (American Association for Cancer Research, 2021)Purpose: Characterization of the T-cell receptor (TCR) reper- toire may be a promising source for predictive biomarkers ...